Effect of levothyroxine on prolonged nocturnal sleep time and excessive daytime somnolence in patients with idiopathic hypersomnia

Sleep Medicine

Volumn 12, Issue 6, 2011, Pages 578-583

  Shinno, Hideto ^a   Ishikawa, Ichiro ^a   Yamanaka, Mami ^a   Usui, Ai ^a   Danjo, Sonoko ^a   Inami, Yasushi ^b   Horiguchi, Jun ^b   Nakamura, Yu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Epworth Sleepiness Scale; Excessive daytime somnolence; Idiopathic hypersomnia; Idiopathic hypersomnia with long sleep time; International Classification of Sleep Disorders; Levothyroxine

Indexed keywords

LEVOTHYROXINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC HYPERSOMNIA; MALE; MORNING DOSAGE; NIGHT SLEEP; OPEN STUDY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEP DISORDER; SLEEP TIME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; FEMALE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SLEEP; SLEEP STAGES; THYROXINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79957972728     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.02.004     Document Type: Article

References (26)

1. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd edition: diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep medicine, 2005.
2. Bassetti CL, Pelayo R, Guilleminault C. Idiopathic hypersomnia. In: Kryger M, Roth T, Dement W, editors. Principles and practice of sleep medicine, 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 791-800.
3. Montplaisir J., de Champlain J., Young S.N., Missala K., Sourkes T.L., Walsh J., et al. Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurol 1982, 32:1299-1302.
4. Faull K.F., Thiemann S., King R.J., Guilleminault C. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report. Sleep 1986, 9:246-249.
5. Mitler M.M., Hajdukovic R., Erman M., Koziol J.A. Narcolepsy. J Clin Neurophysiol 1990, 7:93-118.
6. Shinno H., Inami Y., Inagaki T., Kawamukai T., Utani E., Nakamura Y., et al. Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism. Gen Hosp Psychiatry 2009, 31(2):190-193.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association. Washington, D.C.; 1994.
8. Rechtschaffen A, Kales A. A Manual of standardized terminology, techniques, and scoring system for sleep states of human subjects. Washington, DC: USPHS Publication No. 204. US Government printing Office; 1968.
9. Carskadon M.A., Dement W.C., Milter M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the Multiple Sleep Latency Test (MSLT), a standard measure of sleepiness. Sleep 1986, 9:519-524.
10. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14(6):540-545.
11. Kushida C.A., Chang A., Gadkary C., Guilleminault C., Carrillo O., Dement W.C. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med 2001, 2(5):389-396.
12. Winokur A., Manaker S., Kreider M. TRH and TRH receptors in the spinal cord. Ann New York Acad Sci 1989, 553:314-324.
13. Kolesnick R.N., Gershengorn M.C. Thyrotropin-releasing hormone and the pituitary: new insights into the mechanisms of stimulated secretion and clinical usage. Am J Med 1985, 79:729-739.
14. Riehl J., Honda K., Kwan M., Hong J., Mignot E., Nishino S. Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy. Neuropsychopharmacology 2000, 23:34-45.
15. Momiyama T., Ishihara K., Kimura K., Todo N., Fujita Y., Serikawa T., et al. Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue on spontaneously-epileptic rats. Epilepsia 1996, 37(4):328-331.
16. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21(5):1787-1794.
17. Nishino S., Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997, 52:27-78.
18. Strawn J.R., Ekhator N.N., D'Souza B.B., Geracioti T.D. Pituitary-thyroid state correlates with central dopaminergic and serotonergic activity in healthy humans. Neuropsychobiology 2004, 49(2):84-87.
19. Steininger T.L., Alam M.N., Gong H., Szymusiak R., McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999, 840:138-147.
20. Wu M.F., Gulyani S.A., Yau E., Mignot E., Phan B., Siegel J.M. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 1999, 91(4):1389-1399.
21. Dratman M.B., Gordon J.T. Thyroid hormones as neurotransmitters. Thyroid 1996, 6:639-647.
22. Upadhyaya L., Agrawal J.K. Effect of l-thyroxine and carbimazole on brain biogenic amines and amino acids in rats. Endocr Res 1993, 19(2-3):87-99.
23. Dratman M.B., Futaesaku Y., Crutschfield F.L., et al. Iodine-125-labeled triiodothyronine in rat brain: evidence for localization in discrete neural systems. Science 1982, 215(4530):309-312.
24. Lin C.C., Tsan K.W., Chen P.J. The relationship between sleep apnea syndrome and hypothyroidism. Chest 1992, 102(6):1663-1667.
25. Jha A., Sharma S.K., Tandon N., Lakshmy R., Kadhiravan T., Handa K.K., et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 2006, 7(1):55-61.
26. Misiolek M., Marek B., Namyslowski G., Scierski W., Zwirska-Korczala K., Kazmierczak-Zagorska Z., et al. Sleep apnea syndrome and snoring in patients with hypothyroidism with relation to overweight. J Physiol Pharmacol 2007, 58(S1):77-85.